Abbott Laboratories (ABT) said Wednesday that the U.S. Food and Drug Administration approved its Architect Stat High Sensitivity Troponin-I blood test that could help detect heart attacks faster and more accurately than the standard troponin tests.
from RTT - Biotech https://ift.tt/2l8rYOQ
via IFTTT
No comments:
Post a Comment